A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus

Clinical trial NCT00212641 · COMPLETED

Trial details

NCT number: NCT00212641
Sponsor: Ono Pharma USA Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-06-01
Primary completion: 2007-10-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.